Health
WHO approves two new Ebola vaccines for trials in DR Congo outbreak
November 4, 2026 at 09:31 PM
Coverage
3 reports · 2 in Arabic, 1 in English · over 3 hours
AJAl Jazeera English
WHO approves trials for two new Ebola vaccines
(opens the publisher’s site)
يواليوم السابع
الصحة العالمية: إعلان نتائج تجارب لقاحات إيبولا 2027.. وارتفاع حالات الكوليرا بالكونغو
(opens the publisher’s site)
يواليوم السابع
الصحة العالمية: لقاحان مرشحان للانضمام لتجربة تطعيمات إيبولا لسلالة بونديبوجيو
(opens the publisher’s site)WHO expert groups recommended adding two vaccine candidates to the ongoing clinical trial against the Bundibugyo strain in DR Congo.
- WHO expert groups recommended adding the University of Oxford's ChAdOx1 vaccine, developed with the Serum Institute of India, and Moderna's mRNA-1469 to the trial.
- The Bundibugyo strain has killed more than 5,300 people, most in DR Congo, since May; Africa CDC confirmed 10,444 cases.
- Initial results from the trial, led by DR Congo's National Institute for Biomedical Research, are expected in early 2027.
- WHO chief Tedros Adhanom Ghebreyesus urged countries to lift travel restrictions, saying they penalize transparent reporting.